Novartis drug cuts recurrence risk by 25% in early-stage breast cancer
By Ludwig Burger FRANKFURT (Reuters) – Novartis breast cancer drug Kisqali cut the risk of...
By Ludwig Burger FRANKFURT (Reuters) – Novartis breast cancer drug Kisqali cut the risk of...
A look at the day ahead in U.S. and global markets from Mike Dolan Amid...
A look at the day ahead in U.S. and global markets from Mike Dolan Investor...
A look at the day ahead in U.S. and global markets from Mike Dolan Just...
A look at the day ahead in U.S. and global markets from Mike Dolan. As...
By Valentina Za and Giulio Piovaccari MILAN (Reuters) – In 1977, a Ferrari owner offloaded...
A look at the day ahead in U.S. and global markets from Mike Dolan World...
By Nick Carey LONDON (Reuters) – Legacy automakers got off to a late start with...
LONDON (Reuters) – A look at the day ahead in U.S. and global markets from...
(Refiling to fix formatting issue.) A look at the day ahead in U.S. and global...